Shelley Thunen - Jul 1, 2024 Form 4 Insider Report for RxSight, Inc. (RXST)

Role
Chief Financial Officer
Signature
/s/ Shelley Thunen
Stock symbol
RXST
Transactions as of
Jul 1, 2024
Transactions value $
-$923,833
Form type
4
Date filed
7/2/2024, 04:25 PM
Previous filing
May 2, 2024
Next filing
Jul 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction RXST Common Stock Options Exercise $156 K +10 K +71.75% $15.60 23.9 K Jul 1, 2024 Direct
transaction RXST Common Stock Sale -$476 K -8.15 K -34.03% $58.41 15.8 K Jul 1, 2024 Direct F1, F2
transaction RXST Common Stock Sale -$110 K -1.85 K -11.74% $59.48 13.9 K Jul 1, 2024 Direct F1, F3
transaction RXST Common Stock Sale -$386 K -6.6 K -78.54% $58.55 1.8 K Jul 1, 2024 See footnote F1, F4, F5
transaction RXST Common Stock Sale -$107 K -1.8 K -100% $59.56 0 Jul 1, 2024 See footnote F1, F5, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RXST Stock Option (right to buy) Options Exercise $0 -10 K -21.37% $0.00 36.8 K Jul 1, 2024 Common Stock 10 K $15.60 Direct F7

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted on September 14, 2023 by the Reporting Person.
F2 Represents the weighted average share price of an aggregate total of 8,146 shares sold in the price range of $58.205 to $58.87 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Represents the weighted average share price of an aggregate total of 1,854 shares sold in the price range of $59.25 to $59.725 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4 Represents the weighted average share price of an aggregate total of 6,599 shares sold in the price range of $58.07 to $59.0117 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F5 Shares held by the Shelley B. Thunen Revocable Family Trust, as Amended, for which the Reporting Person serves as trustee.
F6 Represents the weighted average share price of an aggregate total of 1,803 shares sold in the price range of $59.10 to $59.67 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F7 Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2015 Equity Incentive Plan, as amended) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 22, 2021.